Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
AbbVie, adalimumab, adaptive, ahead, aimed, angina, apotex, ASCO, ASN, ATRA, Avastin, Balachandran, balugrastim, BCA, belonging, BESP, bioequivalence, biopharmaceutical, BP, brodalumab, Carolina, CaSR, Celltech, cheaper, cholesterol, clarifying, cognitive, College, commentary, confronted, counterfeit, counterfeiting, curbing, cyber, Cynthia, DC, deCODE, destruction, devote, Durgin, eckert, engineering, exacting, extracellular, familial, fatal, flexibility, footprint, foster, frame, Freeman, GCTB, German, glycine, great, greatly, guilty, Hood, HUMIRA, hyperlipidemia, hypersensitivity, incentivized, infarction, infliximab, Inspector, intrusion, IQWiG, irreversible, ixekizumab, KAI, Kenneth, landscape, Latin, leader, Leroy, linked, LP, Madhavan, Madhu, minimal, minimize, misbranding, misdemeanor, MN, multitude, Mustafa, Neupeg, Nevzat, NHL, NOL, outlicensing, page, passage, Patton, pedigree, Pharma, pioneer, plea, Poland, preexisting, prepaid, privacy, prolonged, prominence, Purnell, rare, redemption, Reed, regularly, relapsed, REMICADE, repeal, replenished, requisite, residential, rituximab, romosozumab, Rosenblum, ROW, SCAN, schizophrenia, spur, statin, stolen, stored, strength, sum, supplementary, surface, surrogate, Taxpayer, theft, tibia, today, TPE, transit, transition, transitioning, trastuzumab, trebananib, Turkey, Tyler, ulcerative, unanticipated, unavailable, unbilled, undiscounted, unlawfully, unsafe, unstable, vertebral, vitro, withholding, worsening, Xeljanz
Removed:
accompanied, Advisor, ALJ, Alliance, alternatively, amounting, amplify, Anna, anticipation, arm, asLarson, assert, asserting, attracting, awarded, AWP, backed, background, Baxter, bear, Behring, Beier, bill, biology, BioScience, Bonanni, broadly, captionedIn, captionedLarson, carboplatin, cellular, Chevron, collective, column, comment, concentrate, Constance, constitute, consumer, contractility, convict, counted, Cytyc, Daiichi, Dear, deceptive, dermatology, detailed, Dey, diphosphate, discontinue, dispensing, dissemination, Electric, elevating, enforceable, England, entitledThe, EPO, estimable, exemption, exercising, Fabrizio, falsely, forfeiture, FOSAMAX, Fujisawa, furnish, Gensia, geographical, GRANULOKINE, Grumman, guideline, half, Hartson, hazard, head, hematocrit, hereto, Hoechst, Hogan, holding, House, hypocalcemia, Ilypsa, inhibit, initiating, innovating, inRosenblum, instruction, interval, ischemia, ITC, Journal, Justice, locally, Marion, MCI, MDL, Mellon, modality, Mountain, neck, Northern, Northrop, notified, OCI, ofDurgin, ofRosenblum, ONJ, opposing, opposition, paclitaxel, pancreatic, pediatric, peg, penetration, Pharmacia, Pharmacopoeia, Philadelphia, predominately, proceed, proceeding, quickly, registry, rehearing, reimburse, resolving, restructure, retaining, rheumatology, Richo, Roussel, Sandoz, Sankyo, satisfied, secreted, secretion, selectively, SF, spent, stipulated, studied, suited, suspended, tentative, terminating, territory, Tevagrastim, theIn, Thompson, timetable, tissue, titledBirch, track, training, trustee, Turner, undetermined, unlawful, unusual, Upjohn, vacated, violating, vision, weighting, Welfare, withdrew, yearly, ZLB
Filing tables
Filing exhibits
- 10-K Annual report
- 3.5 Charter Certificate
- 10.4 Amended Performance Award Program
- 10.6 Amended and Restated Director Program
- 10.8 Form of Restricted Stock Unit Agreement for Director Program
- 10.17 First Amendment to the Executive Incentive Plan
- 10.51 Amendment 1 to License Agreement
- 10.52 Amendment 2 to License Agreement
- 10.54 Collaboration and License Agreement and Amendment 1
- 10.58 Amendment 1 to Collaboration Agreement
- 10.61 Amendment 2 to Expansion Agreement
- 10.63 Amendment 1 to Sourcing and Supply Agreement
- 21 Subsidiaries of the Company
- 31 Rule 13A-14(A) Certifications
- 32 Section 1350 Certifications
Related press release
AMGN similar filings
Filing view
External links
Exhibit 3.5
CERTIFICATE OF CHANGE OF LOCATION OF REGISTERED OFFICE
AND OF REGISTERED AGENT
OF
AMGEN INC.
It is hereby certified that:
1. | The name of the corporation (hereinafter called the "corporation") is |
AMGEN INC.
2. | The registered office of the corporation within the State of Delaware is hereby |
changed to 2711 Centerville Road, Suite 400, City of Wilmington 19808, County of New Castle.
3. | The registered agent of the corporation within the State of Delaware is hereby |
changed to Corporation Service Company, the business office of which is identical with the
registered office of the corporation as hereby changed.
4. | The corporation has authorized the changes hereinbefore set forth by resolution |
of its Board of Directors.
Signed on January 2, 2009.
/s/ Mark A. Schlossberg
Name: Mark A. Schlossberg
Title: Asst. Secretary and V.P.
1